LONDON, May 25 (Reuters) - Belgian drugmaker UCB is to test its rheumatoid arthritis drug Cimzia in a head-to-head clinical trial against Abbott's Humira, as competition heats up in the market. Humira ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback